PAREXEL
Live / Registered — Registered and renewed (as of 27 Mar 2021)
What this means for you
Registered since 28 Nov 2000. The owner can stop confusingly similar uses in the classes it covers; it stays on the register as long as the owner keeps up the maintenance filings (next due by 28 Nov 2020).
Record
- Serial number
- 75644415
- Registration number
- 2407845
- Mark type
- Word mark
- Filed
- 05 Feb 1999
- Published for opposition
- 05 Sept 2000
- Registered
- 28 Nov 2000
- Next maintenance due
- 28 Nov 2020
- Attorney of record
- Douglas R. Wolf
Goods and services
- Class 035 — Advertising and business services: MARKET RESEARCH IN THE FIELD OF INTERNATIONAL HEALTH, THE PHARMACEUTICAL INDUSTRY, THE BIOTECHNOLOGY INDUSTRY AND THE MEDICAL DEVICE AND DIAGNOSTICS INDUSTRIES; BUSINESS MARKETING CONSULTING SERVICES IN THE FIELD OF INTERNATIONAL HEALTH, THE PHARMACEUTICAL INDUSTRY, THE BIOTECHNOLOGY INDUSTRY AND THE MEDICAL DEVICE AND DIAGNOSTICS INDUSTRIES; MARKET ANALYSIS; PROVIDING BUSINESS INFORMATION, NAMELY, INFORMATION USEFUL FOR THE INTRODUCTION OF NEW PRODUCTS IN THE FIELD OF INTERNATIONAL HEALTH, THE PHARMACEUTICAL INDUSTRY, THE BIOTECHNOLOGY INDUSTRY AND THE MEDICAL DEVICE AND DIAGNOSTICS INDUSTRIES; PROVIDING STATISTICAL INFORMATION IN THE FIELD OF INTERNATIONAL HEALTH, THE PHARMACEUTICAL INDUSTRY, THE BIOTECHNOLOGY INDUSTRY AND THE MEDICAL DEVICE AND DIAGNOSTICS INDUSTRIES; AND DATA PROCESSING SERVICES IN THE FIELD OF INTERNATIONAL HEALTH, THE PHARMACEUTICAL INDUSTRY, THE BIOTECHNOLOGY INDUSTRY AND THE MEDICAL DEVICE AND DIAGNOSTICS INDUSTRIES
- Class 042 — Scientific and technological services: CONSULTING SERVICES IN THE FIELD OF CONDUCTING CLINICAL TRIALS, REGULATORY AFFAIRS, DRUG DEVELOPMENT, MANUFACTURING COMPLIANCE AND VALIDATION, ADVANCED TECHNOLOGY, CLINICAL BENCHMARKING AND PERFORMANCE IMPROVEMENT USED IN CONNECTION WITH THE TRAINING OF PROFESSIONALS IN THE FIELD OF INTERNATIONAL HEALTH, THE PHARMACEUTICAL INDUSTRY, THE BIOTECHNOLOGY INDUSTRY AND THE MEDICAL DEVICE AND DIAGNOSTICS INDUSTRIES; AND CONSULTATION IN THE FIELD OF PUBLISHING RELATING TO CONDUCTING CLINICAL TRIALS, REGULATORY AFFAIRS, DRUG DEVELOPMENT, MANUFACTURING COMPLIANCE AND VALIDATION, ADVANCED TECHNOLOGY, CLINICAL BENCHMARKING AND PERFORMANCE IMPROVEMENT IN THE FIELD OF INTERNATIONAL HEALTH, THE PHARMACEUTICAL INDUSTRY, THE BIOTECHNOLOGY INDUSTRY AND THE MEDICAL DEVICE AND DIAGNOSTICS INDUSTRIES
Owner
- PAREXEL INTERNATIONAL (MA) CORPORATION, NEWTON, MA, US
- PAREXEL International Corporation, Billerica, MA, US
- PAREXEL International Corporation, Waltham, MA, US
- PAREXEL International Corporation, Waltham, MA, US
Prior registrations
Prosecution history
- 17 Feb 2023 — APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
- 17 Feb 2023 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 17 Feb 2023 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
- 17 Feb 2023 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
- 17 Feb 2023 — TEAS CHANGE OF OWNER ADDRESS RECEIVED
- 08 Feb 2023 — AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
- 27 Mar 2021 — NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
- 27 Mar 2021 — REGISTERED AND RENEWED (SECOND RENEWAL - 10 YRS)
- 27 Mar 2021 — REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
- 10 Feb 2021 — ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
- 21 Jan 2021 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
- 29 Oct 2020 — TEAS SECTION 8 & 9 RECEIVED
- 28 Nov 2019 — COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
- 29 May 2019 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
- 29 May 2019 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED